O-6 Gene alterations in ctDNA related to the resistance mechanism of anti-EGFR antibodies and clinical efficacy outcomes of anti-EGFR antibody rechallenge plus trifluridine/tipiracil in metastatic colorectal cancer patients in WJOG8916G trial
Titel:
O-6 Gene alterations in ctDNA related to the resistance mechanism of anti-EGFR antibodies and clinical efficacy outcomes of anti-EGFR antibody rechallenge plus trifluridine/tipiracil in metastatic colorectal cancer patients in WJOG8916G trial
Auteur:
Takahashi, N. Izawa, N. Nishio, K. Masuishi, T. Shoji, H. Yamamoto, Y. Matsumoto, T. Sugiyama, K. Kajiwara, T. Kawakami, K. Aomatsu, N. Kawakami, H. Esaki, T. Narita, Y. Hara, H. Horie, Y. Boku, N. Miura, K. Moriwaki, T. Shimokawa, M. Nakajima, T. Muro, K.